Controversially, the effect of anti-VEGF/R inhibitors on metastasis formation has been a matter of debate as data demonstrate that inhibition of VEGFR-2 with monoclonal antibodies or small molecules lead to an increase in metastases and more invasive tumor cell phenotypes [36]–[38]. This evidence concerns the gene KDR and neoplasm.